ID

33807

Descripción

The Beneficial Effect of Vitamin D Supplement to Peg Interferon Alpha 2a or to Telbivudine Monotherapy in Patients With Chronic Hepatitis B Virus (HBV) Infection; ODM derived from: https://clinicaltrials.gov/show/NCT01083251

Link

https://clinicaltrials.gov/show/NCT01083251

Palabras clave

Versiones (1)
  1. 28/12/18 28/12/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

28 de diciembre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Hepatitis B Virus NCT01083251

Inglés

Eligibility Hepatitis B Virus NCT01083251

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients were eligible if they had been hbsag positive for at least 6 months,
Descripción

Hepatitis B surface antigen positive Duration

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0149709
UMLS CUI [1,2]
C0449238
patients were hbeag positive or negative,
Descripción

Hepatitis B e antigen positive | Hepatitis B e antigen negative

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392390
UMLS CUI [2]
C0948827
patients had increased serum alt levels between 1 and 10 times the upper limit of normal (uln),
Descripción

Alanine aminotransferase increased

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0151905
patients had serum hbv-dna levels greater than 1.0 x 10e5 copies/ml (2.0 x 10e4 iuml), and
Descripción

Hepatitis B DNA Measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3641250
patients had findings on a liver biopsy within the preceding 12 months that were consistent with the presence of chronic hepatitis b.
Descripción

Signs and Symptoms Biopsy of liver | Consistent with Chronic Hepatitis B

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0037088
UMLS CUI [1,2]
C0193388
UMLS CUI [2,1]
C0332290
UMLS CUI [2,2]
C0524909
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
decompensated liver disease,
Descripción

Decompensated liver disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4075847
antiviral therapy within 6 months before randomization,
Descripción

Antiviral Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0280274
viral co-infections (hepatitis c virus, hepatitis delta virus, or human immunodeficiency virus), or
Descripción

Coinfection Viral | HCV coinfection | Hepatitis Delta Virus Coinfection | HIV coinfection

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0275524
UMLS CUI [1,2]
C0521026
UMLS CUI [2]
C1698259
UMLS CUI [3,1]
C0011220
UMLS CUI [3,2]
C0275524
UMLS CUI [4]
C4062778
pre-existent neutropenia or thrombocytopenia.
Descripción

Neutropenia Pre-existing | Thrombocytopenia Pre-existing

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0027947
UMLS CUI [1,2]
C2347662
UMLS CUI [2,1]
C0040034
UMLS CUI [2,2]
C2347662
Volver a la parte superior de la página

Similar models

Eligibility Hepatitis B Virus NCT01083251

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Hepatitis B surface antigen positive Duration
Item
patients were eligible if they had been hbsag positive for at least 6 months,
boolean
C0149709 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Hepatitis B e antigen positive | Hepatitis B e antigen negative
Item
patients were hbeag positive or negative,
boolean
C0392390 (UMLS CUI [1])
C0948827 (UMLS CUI [2])
Alanine aminotransferase increased
Item
patients had increased serum alt levels between 1 and 10 times the upper limit of normal (uln),
boolean
C0151905 (UMLS CUI [1])
Hepatitis B DNA Measurement
Item
patients had serum hbv-dna levels greater than 1.0 x 10e5 copies/ml (2.0 x 10e4 iuml), and
boolean
C3641250 (UMLS CUI [1])
Signs and Symptoms Biopsy of liver | Consistent with Chronic Hepatitis B
Item
patients had findings on a liver biopsy within the preceding 12 months that were consistent with the presence of chronic hepatitis b.
boolean
C0037088 (UMLS CUI [1,1])
C0193388 (UMLS CUI [1,2])
C0332290 (UMLS CUI [2,1])
C0524909 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Decompensated liver disease
Item
decompensated liver disease,
boolean
C4075847 (UMLS CUI [1])
Antiviral Therapy
Item
antiviral therapy within 6 months before randomization,
boolean
C0280274 (UMLS CUI [1])
Coinfection Viral | HCV coinfection | Hepatitis Delta Virus Coinfection | HIV coinfection
Item
viral co-infections (hepatitis c virus, hepatitis delta virus, or human immunodeficiency virus), or
boolean
C0275524 (UMLS CUI [1,1])
C0521026 (UMLS CUI [1,2])
C1698259 (UMLS CUI [2])
C0011220 (UMLS CUI [3,1])
C0275524 (UMLS CUI [3,2])
C4062778 (UMLS CUI [4])
Neutropenia Pre-existing | Thrombocytopenia Pre-existing
Item
pre-existent neutropenia or thrombocytopenia.
boolean
C0027947 (UMLS CUI [1,1])
C2347662 (UMLS CUI [1,2])
C0040034 (UMLS CUI [2,1])
C2347662 (UMLS CUI [2,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial